Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion

Sponsor
Lahey Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT00735865
Collaborator
(none)
55
2
4
70
27.5
0.4

Study Details

Study Description

Brief Summary

To determine if the types and amount of bacteria or other germs change over time after the routine procedure of blockage of tear drainage duct in the treatment of dry eye condition or other condition benefiting from a tear drainage blockage

Condition or Disease Intervention/Treatment Phase
  • Procedure: Punctal plugs, punctal cautery
  • Procedure: Punctal Plug, Punctal thermocauterization
  • Procedure: Silicone plug or thermodynamic hydrophobic acrylic plug
  • Other: Previous subjects with Punctal occlusion
N/A

Detailed Description

This study will investigate the impact of punctal occlusion on the ocular microbial flora. Current thought is that punctal occlusion causes retention of inflammatory mediators on the ocular surface which may produce pathology, we hypothesize that blockage of the nasolacrimal drainage system may allow colonization of the ocular surface by potentially pathogenic ubiquitous organisms (which may produce exotoxins and other biologic products) that may be responsible for signs and symptoms seen in some patients. Additionally, the presence of the silicone foreign body(punctal plug) may act as a nidus for bacterial adhesion with biofilm production (which is known to occur with Pseudomonas sp and other organisms). There would thus be a paradigm shift of our current understanding of the pathophysiology of punctal occlusion. Additionally, the choice of antimicrobials for the treatment of infections in patients with punctal occlusion may need to be modified if the microbial flora is found to be different in patients with punctal occlusion.

The ocular flora may be different inpatients with severe dry eye or other chronic pathologic conditions, which are frequent indications for punctal occlusion. However, from our retrospective review, we could not determine if there was a change in the microbial flora following plug placement with colonization with these "unusual organisms" since baseline cultures prior to punctal plug placement were not obtained.

We will try to differentiate any effect on the microbial flora caused by the silicone plug or acrylic plug(as a foreign body) versus the punctal closure by thermocautery. (Punctal thermocauterization is an alternative method of punctal closure which is 1) the preferred choice by some ophthalmologists for all their cases, or 2) when the dry eye is severe and irreversible punctal occlusion is desired or 3) if punctal plugs can not be retained due to the large size of the patients punctal). The thermodynamic hydrophobic acrylic plug(SmartPLUG) approved by the FDA for punctal occlusion with the same indications as the traditional silicone plug.

Study Design

Study Type:
Interventional
Actual Enrollment :
55 participants
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion
Study Start Date :
Jul 1, 2003
Actual Primary Completion Date :
Apr 1, 2009
Actual Study Completion Date :
May 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Procedure: Punctal plugs, punctal cautery
25 subjects(20 silicone punctal plugs, 5 punctal cautery) The procedure will be based on clinical indication. Randomized one eye for study. Baseline cultures of lid margin & tarsal/inferior fornix conjunctiva obtained & plated according to protocol

Active Comparator: 2

Procedure: Punctal Plug, Punctal thermocauterization
Up to 5 subjects. Subjects in need of punctal occlusion(No preference for punctal thermocauterization or punctal occlusion by silicone plug). Randomize one eye to silicone punctal plug occlusion, the other eye to punctal thermocauterization. This group ONLY, cultures will be obtained of the lid margin & conjunctiva/inferior fornix of BOTH eyes

Active Comparator: 3

Procedure: Silicone plug or thermodynamic hydrophobic acrylic plug
Up to 5 subjects. Subjects in need of punctal occlusion(not preference for punctal occlusion by silicone plug or by the thermodynamic hydrophobic acrylic plug). Randomize one eye to silicone punctal plug occlusion, the other eye to acrylic punctal plug occlusion. In this group ONLY cultures will be obtained of the lid margin and conjunctiva/inferior fornix of BOTH eyes

Active Comparator: 4

Other: Previous subjects with Punctal occlusion
Up to 20 subjects(15 subjects with silicone punctal plug closure and 5 subjects with punctal closure by thermocauterization)Subjects who have previously had punctal occlusion who have symptoms and/or signs thought to be secondary to punctal occlusion. Lid margin and conjunctiva/inferior fornix of eye with greatest sign or symptoms will be cultured/plated according to standard protocol.

Outcome Measures

Primary Outcome Measures

  1. Impact of punctal occlusion on the ocular microbial flora [1 year(3mo, 6mo, 12 mo culture/follow up visits)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years and older

  • Able to sign Informed Consent

  • Clinical indication for punctal plug insertion or punctal cautery or symptomatic patients who have previously had punctal occlusion

  • Clinical indication for punctal plug removal(Partial extrusion, discomfort) increased signs of ocular irritation with punctate keratopathy, punctal inflammation).

  • Able to make follow up visit schedule

Exclusion Criteria:
  • Subjects without dry eye

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lahey Clinic, Inc. Burlington Massachusetts United States 01805
2 Lahey Clinic North Peabody Massachusetts United States 01960

Sponsors and Collaborators

  • Lahey Clinic

Investigators

  • Principal Investigator: Sarkis H. Soukiasian, M.D., Lahey Clinic, Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00735865
Other Study ID Numbers:
  • 2003-049
First Posted:
Aug 15, 2008
Last Update Posted:
May 25, 2009
Last Verified:
May 1, 2009

Study Results

No Results Posted as of May 25, 2009